Adiponectin and intracardiac haemodynamics state in hypertensive overweight patients

  • N. I. Petrik State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"
Keywords: adiponectin, arterial hypertension, overweight patients, intracardiachaemodynamics


Investigation of adiponectin levels andintracardiac haemodynamic statehas been done in 96 patients divided into two groups (1st group – 64 hypertensive (stage II) overweight patients, medium age 59,0 (48,0–63,0) years; 2-nd group – 32 hypertensive (stage II) patients, medium age 58,0 (53,0–63,0) years, normal weight). Dependences between the left auricle size, blood pressure, and BMI increase, as well as between the left ventricle remodelling character and BMI in the surveyed patients were uncovered. Theconcentric left ventricle hypertrophy observed in the surveyed patients was characterised by normal contractility, leftventricle posteriorwall relative thickness increase, and normal or reduced end-diastolic volume. The blood serum adiponectin level in hypertensive (stage ІІ) overweight patients was significantly (nearly 3 times) lower as compared to the group of hypertensive (stage ІІ) patients who had normal weight.


Ametov AS, Pashkova EY, Ramazanova ZD, Darsigova MN Obesity as a non-infectious epidemic of the 21st century. Current ideas about pathogenesis, risks and approaches to pharmacotherapy. Endokrinologiya: novosti, mneniya, obucheniye. 2019; 8 (2): 57–66. DOI: 10.24411/2304-9529-2019-12007.

Potekhin NP, Sarkisov KA, Orlov FA et al. The effect of abdominal obesity on left ventricular myocardial remodeling in patients with arterial hypertension. Klinicheskaya meditsina. 2015; 7: 67–70.

Nyushko TY. Structural and functional changes of the left ventricle and vessels in patients with stage II hypertension, depending on the type of daily profile of blood pressure. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu. 2015; 19 (2): 379–384.

Kologrivova IV, Vinnitsa IV, Koshelskaya OA, Suslova TE. Visceral obesity and cardiometabolic risk: features of hormonal and immune regulation. Ozhireniye i metabolizm. 2017; 14 (3): 3–10. DOI: 10.14341/omet201733-10.

Jayedi A, RashidyPour A, Khorshidi M, ShabBidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and doseresponse meta-analysis of more than 2.3 million participants. Obes Rev. 2018; 19 (5): 654–667. DOI: 10.1111/obr.12656.

Larsen MA, Isaksen VT, Paulssen EJ et al. Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals. Endocrine. 2019; 66 (3): 517–525. DOI: 10.1007/s12020-019-02102-9.

Yanai H, Yoshida H. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. Int J Mol Sci. 2019; 20 (5): 1190. DOI: 10.3390/ijms20051190.

Statsenko ME., Derevyanchenko MV. The state of the main arteries, vascular age in patients with arterial hypertension and obesity: the role of leptin and adiponectin. Rossiyskiy kardiologicheskiy zhurnal. 2019; 24 (1): 7–11. DOI: 10.15829/1560-4071-2019-1-7-11.

Febriza A, Ridwan R, As'ad S et al. Adiponectin and Its Role in Inflammatory Process of Obesity. Molecular and Cellular Endocrinology. 2019; 3, (1): 40–48. DOI: 10.21705/mcbs.v3i2.66.

Vavilova TP, Pleten AP, Mikheev RK. The biological role of adipokines as markers of pathological conditions. Voprosy pitaniya. 2017; 86 (2): 5–13.

Perrotta F, Nigro E, Mollica M et al. Pulmonary Hypertension and Obesity: Focus on Adiponectin. Int J Mol Sci. 2019; 20 (4): 912. DOI: 10.3390/ijms20040912.

Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH).Eur Heart J. 2018; 39 (33): 3021–3104. DOI: 10.1093/eurheartj/ehy339.

Peri Okonny PA, Ayers C, Maalouf N et al. Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study. Diabetes Metab Res Rev. 2017; 33: e2840. DOI: 10.1002/dmrr.2840.

Mikcheeva K, Berkovich O, Ionin V et al. Adiponectin and Risk of Severe Coronary Artery Disease. Atherosclerosis. 2019; 287: e255. https://

Zlibut A, Agoston-Coldea L, Mocan T, Bocsan IC and Mocan L. Biomarkers in Metabolic Syndrome. Ultimate Guide to Insulin. / Edited by Gaffar Zaman. Intech Open, 2019. C. 89–106. DOI: 10.5772/intechopen.79427.

Gariballa S, Alkaabi J, Yasin J et al. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocrine Disorders. 2019; 19 (1): 55 DOI: 10.1186/s12902-019-0386-z.

How to Cite
Petrik, N. I. (2020). Adiponectin and intracardiac haemodynamics state in hypertensive overweight patients. Modern Medical Technology, (1(44), 52-59.
Original research